Ticker Details
NeoGenomics, Inc. NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee.
IPO Date:	December 10, 2012
Sector:	Healthcare
Industry:	Life Sciences Tools and Services
Market Cap:	$2.18B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.37 | 2.53%
Avg Daily Range (30 D):	$0.45 | 2.95%
Avg Daily Range (90 D):	$0.37 | 3.14%

Institutional Daily Volume
Avg Daily Volume:	.76M
Avg Daily Volume (30 D):	2.08M
Avg Daily Volume (90 D):	2.09M

Trade Size
Avg Trade Size (Sh.):	94
Avg Trade Size (Sh.) (30 D):	79
Avg Trade Size (Sh.) (90 D):	85

Institutional Trades
Total Institutional Trades:	4,193
Avg Institutional Trade:	$2.22M
Avg Institutional Trade (30 D):	$3.4M
Avg Institutional Trade (90 D):	$3.07M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$2.84M
Avg Closing Trade (30 D):	$6.35M
Avg Closing Trade (90 D):	$5.09M
Avg Closing Volume:	168.07K

News

Jun 25, 2025 @ 6:51 AM 3 Hot Trades for Insiders, But Are They Good Buys ... Source: Marketbeat.Com

May 6, 2025 @ 4:20 PM It's Not Too Late to Jump on These Under-the-Radar... Source: Marketbeat.Com

Apr 8, 2025 @ 8:48 AM Minimal Residual Disease Testing Market Forecast R... Source: Researchandmarkets.Com

Feb 17, 2025 @ 10:28 PM Not Just a DEX: How Pineapple’s Mystery Mar... Source: N/A

Jan 15, 2025 @ 3:10 PM Cutting-Edge Cancer Therapies Lead the Way into a ... Source: Prnewswire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS
Diluted EPS
Revenue	$766.3M	$201.66M	$186.67M
Gross Profit	$336.53M	$91.88M	$80.86M
Net Income / Loss	$-51.88M	$2.24M	$-17.11M
Operating Income / Loss	$-68.44M	$-9.77M	$-18.24M
Cost of Revenue	$429.76M	$109.78M	$105.81M
Net Cash Flow	$-9.24M	$-.6M	$-13.48M
PE Ratio

Splits
Apr 16, 2003	1:100
Nov 17, 2000	4:1